Latest California Healthline Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
KHN’s ‘What The Health?’: We Spend HOW MUCH On Health Care?
The annual accounting of national health spending is out. And the 2018 health bill for the U.S. was $3.6 trillion, consuming nearly a fifth of the nation’s economy. Meanwhile, Congress is nearing the end of the year without having finished either its annual spending bills or several other high-priority health items. Kimberly Leonard of the Washington Examiner, Joanne Kenen of Politico and Mary Agnes Carey of Kaiser Health News join KHN’s Julie Rovner to discuss this and more. Also, Rovner interviews KHN’s Markian Hawryluk about the latest KHN-NPR “Bill of the Month.”
Medical Device Failures Brought To Light Now Bolster Lawsuits And Research
A retired Oakland, Calif., physician is among the patients citing the once-hidden Food and Drug Administration data in a suit.
No Safety Switch: How Lax Oversight Of Electronic Health Records Puts Patients At Risk
Special interests and congressional inaction blocked efforts to track the safety of electronic medical records, leaving patients at risk.
A Regulatory Haze: Vape Marketers Are Online, Creating New Headaches For Feds
The subculture around vaping has been fueled by social media, and traditional regulations don’t easily address potential pitfalls.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Flavor Bans Multiply, But Menthol Continues to Divide
As states and communities ban the sale of flavored tobacco products linked to vaping, anti-smoking activists are piggybacking on the momentum to target menthol cigarettes. But some African Americans say menthol cigarette bans will lead to discrimination.
FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns
The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.
A Million-Dollar Marketing Juggernaut Pushes 3D Mammograms
Companies are aggressively touting 3D mammograms, although there’s no evidence they save lives.
Vapers Accuse Officials Of Overreach As Investigation Into Deadly Lung Illness Lags
With federal authorities offering few details about what is causing the deadly outbreak of vaping-related lung illnesses, vaping advocates are crafting an alternative narrative reverberating through online communities.